Table 5.
Group | OD570 |
Protection rate (%) |
||||||
---|---|---|---|---|---|---|---|---|
1:4 | 1:8 | 1:16 | 1:2 | 1:4 | 1:8 | 1:16 | ||
CB (50 μg/mL) | 1.940±0.262a | 1.665±0.058a | 1.599±0.161a | 1.368±0.210a | 201.267 | 161.455 | 151.973 | 118.458 |
Epigoitrin (50 μg/mL) | 2.192±0.108a | 1.980±0.246a | 1.833±0.049a | 1.639±0.347a | 237.749 | 207.058 | 185.849 | 157.763 |
PEP portion (1 mg/mL) | 2.437±0.190a | 2.340±0.123a | 2.020±0.319a | 1.695±0.041a | 273.218 | 259.175 | 212.921 | 165.798 |
PEP+ALK+OA (1 mg/mL) | 2.043±0.072a | 2.055±0.009a | 1.743±0.282a | 1.599±0.069a | 216.178 | 217.988 | 172.819 | 151.900 |
Ribavirin (100 μg/mL) | 1.614±0.093a | 1.736±0.307a | 1.441±0.001a | 1.279±0.018a | 154.144 | 171.734 | 129.099 | 105.646 |
Virus control | 0.549±0.690 | − | − | − | − | |||
Cell control | 1.240±0.675 | − | − | − | − |
Notes: Cell control: normal cells without virus infection and drug treatments. Virus control: cells infected with influenza virus. PEP: phenylpropanoids portion; PEP + ALK + OA: the mixtures of phenylpropanoids, alkaloids and organic acid portions. The asterisks indicate a significant difference between the test samples and the virus control according to Duncan's multiple range tests,
P < 0.01.